drugset / Trial / NCT00186706

Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00186706

RandomizedParallel-groupDouble-blindPrevention

Summary

Does an oral selenium supplement increase blood levels of antioxidants in patients with established, smoking-related lung disease? Members of our study group recently discovered that elevated levels of the anti-oxidant GPx-1 may be protective against heart disease. We are studying whether selenium supplementation will improve GPx-1 levels.

Timeline

Start
2005-09
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Selenium Other / unclassified Oral